Stocks Gilead Sciences Inc

More

  • A correction is “clearly on its way” since the start of the year, but investors can still make money in this market environment, said Enzio von Pfeil, CEO of EconomicClock.com. He shared his market strategies.

  • Get calls on Apple, Seagate Tech, Cisco Systems and more.

  • The NASDAQ Composite is continuing to lead its peers.  Not only is the NASDAQ Composite up for its fifth consecutive day today, but the tech-driven index is also outperforming the major U.S. indexes month-to-date, up almost 4.3% as of late Thursday afternoon.

  • Cramer interviews the White House economist Austan Goolsbee. Plus, get midday calls.

  • Plus, find out an even more powerful driver behind the markets these days.

  • Cramer makes the call on viewers' favorite stocks.

  • So far this year, the performance of the biotechnology index has been strong. So is there room for more growth in the sector? Mark Schoenebaum, managing director and senior research analyst at Deutsche Bank Securities shared his stock picks.

  • I don't buy into the silly conspiracy theories that global health authorities worked in cahoots with the big, bad drug companies to gin up a pandemic scare just to goose vaccine and flu drug sales. Try telling that to the family of someone who died from H1N1.

  • Nearly every city and state wants biopharma. They fiercely compete for the relatively clean industry and the well-paid, highly educated jobs it brings.

  • Pfizer headquarters in New York City.

    Pfizer, the world's largest drugmaker, is scheduled to report fourth-quarter results before the opening bell on Wednesday, February 3. Here is a look at how Pfizer shares traded during the most recent earnings reports.

  • If your investment strategy is ‘slow and steady wins the race,’ Pete Najarian has a trade for you.

  • What follows is a look at stocks in the S&P 500 displaying unusual volume in today's trading session.

  • Cramer explains how to avoid the confusion tomorrow.

  • Investors who want to make money in this environment should be buying a different kind of bank, the Mad Money host says.

  • Cramer makes the call on viewers' favorite stocks.

  • I'm gonna avoid all the cliches about JPM being the Super Bowl of investment conferences or the grandaddy of them all. As of earlier this week, JPM says 6,500 people are expected to attend (down slightly from last year,) more than 330 public and private companies are presenting and more than 7,500 so-called one-on-one meetings between analysts/investors and execs have been scheduled. Plus, a whole bunch of other meetings take place on the down low all over the city.

  • The Lightning Round is extended in this CNBC.com exclusive feature.

  • It has been over a month and a half since the US House of Representatives passed its version of health care reform and today, the Senate passed its bill.  Now the two bills must be reconciled and the debate will continue to heat up.  Here are the biggest S&P Health Care gainers and losers over the past 6 months.

  • These companies offer great cash payouts and the potential for upside.

  • With dividends taking on a crucial role as investors rotate out of the riskier trades, how should you be positioned?